Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NPF | Ann: NPF NTA 29-07-2025 $1.12447 | 30/07/25 | 0 | 36 | |||
|
|||||||
NPF | Ann: NPF NTA 28-07-2025 $1.12009 | 29/07/25 | 0 | 63 | |||
|
|||||||
NPF | Ann: NPF NTA 25-07-2025 $1.11631 | 28/07/25 | 0 | 52 | |||
|
|||||||
NPF | Ann: NPF NTA 24-07-2025 $1.11844 | 25/07/25 | 0 | 65 | |||
|
|||||||
NPF | Ann: NPF NTA 23-07-2025 $1.13114 | 24/07/25 | 0 | 58 | |||
|
|||||||
NPF | Ann: NPF NTA 22-07-2025 $1.12109 | 23/07/25 | 0 | 54 | |||
|
|||||||
NPF | Ann: NPF NTA 21-07-2025 $1.13324 | 22/07/25 | 0 | 62 | |||
|
|||||||
NPF | Ann: NPF NTA 18-07-2025 $1.12199 | 21/07/25 | 0 | 56 | |||
|
See All Discussions